Desferal

In some countries, this medicine may only be approved for veterinary use.

In the US, Desferal (deferoxamine systemic) is a member of the following drug classes: antidotes, chelating agents and is used to treat Iron Poisoning - Acute and Iron Poisoning - Chronic.

US matches:

• Desferal

UK matches:

• Desferal Vials, 500mg or 2g (SPC)

Ingredient matches for Desferal

Deferoxamine

Deferoxamine is reported as an ingredient of Desferal in the following countries:

• Ghana


• Guyana


• India


• Kenya


• Libya


• Nigeria


• Russian Federation


• Sudan


• Tanzania


• Turkey


• Zimbabwe

Deferoxamine hydrochloride (a derivative of Deferoxamine) is reported as an ingredient of Desferal in the following countries:

• Czech Republic

Deferoxamine mesilate (a derivative of Deferoxamine) is reported as an ingredient of Desferal in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Bulgaria


• Canada


• Chile


• China


• Colombia


• Denmark


• Finland


• Germany


• Greece


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malaysia


• Malta


• Netherlands


• Norway


• Oman


• Philippines


• Poland


• Portugal


• Romania


• Slovakia


• South Africa


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• United States


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.